SILVERBACK ASSET MANAGEMENT LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 22 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
SILVERBACK ASSET MANAGEMENT LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$3,412,500
-9.0%
6,500,000
-13.3%
0.47%
-8.4%
Q2 2023$3,750,000
+50.0%
7,500,000
+20.0%
0.51%
+50.7%
Q1 2023$2,500,000
-27.5%
6,250,0000.0%0.34%
-28.8%
Q4 2022$3,450,391
-46.8%
6,250,000
-46.8%
0.48%
-48.2%
Q3 2022$6,487,175
+0.0%
11,750,0000.0%0.92%
-8.0%
Q2 2022$6,485,000
+1.8%
11,750,000
-2.1%
1.00%
+15.8%
Q1 2022$6,368,00012,000,0000.86%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2022
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 29,679,000$23,720,0007.42%
SILVERBACK ASSET MANAGEMENT LLC 11,750,000$6,487,1750.92%
DCF Advisers, LLC 1,550,000$884,0000.57%
Context Capital Management, LLC 14,764$8,274,0000.56%
AGF Investments LLC 7,000,000$3,872,0000.36%
WHITEBOX ADVISORS LLC 19,600,000$10,682,0000.30%
Pentwater Capital Management LP 46,411,000$26,134,0000.29%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$11,591,0000.27%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 24,000,000$13,275,0000.24%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 14,900,000$8,493,0000.12%
View complete list of ESPERION THERAPEUTICS INC NE shareholders